DexCom
DXCM
Collegium Pharmaceutical
COLL
Lantheus
LNTH
Cars.com
CARS
YETI Holdings
YETI
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -19.97%12.33M | -15.48%11.21M | -29.75%8.24M | -6.52%48.83M | 12.08%8.42M | -0.76%15.41M | -23.91%13.27M | -0.24%11.73M | 16.86%52.24M | -31.68%7.52M |
Operating revenue | -19.97%12.33M | -15.48%11.21M | -29.75%8.24M | -6.52%48.83M | 12.08%8.42M | -0.76%15.41M | -23.91%13.27M | -0.24%11.73M | 16.86%52.24M | -31.68%7.52M |
Cost of revenue | -4.05%9.09M | -1.85%9.14M | -16.84%8.62M | -0.96%38.87M | 8.40%9.73M | 3.35%9.48M | -16.33%9.31M | 3.79%10.36M | 23.18%39.25M | -1.08%8.97M |
Gross profit | -45.40%3.24M | -47.52%2.08M | -127.37%-375K | -23.32%9.96M | 10.58%-1.3M | -6.68%5.93M | -37.27%3.96M | -22.86%1.37M | 1.16%12.99M | -175.31%-1.46M |
Operating expense | 91.76%2.68M | -5.43%2.28M | 16.87%3.04M | 1.13%9.75M | 67.84%3.35M | -50.09%1.4M | -9.46%2.41M | 18.69%2.6M | 18.53%9.64M | -14.76%1.99M |
Selling and administrative expenses | 43.42%1.65M | 2.24%1.41M | 13.05%1.62M | -9.77%5.28M | 48.48%1.32M | -31.28%1.15M | -24.01%1.38M | -2.98%1.43M | 4.11%5.86M | -46.93%889K |
-General and administrative expense | 43.42%1.65M | 2.24%1.41M | 13.05%1.62M | -9.77%5.28M | 48.48%1.32M | -31.28%1.15M | -24.01%1.38M | -2.98%1.43M | 4.11%5.86M | -46.93%889K |
Research and development costs | 315.32%1.03M | -15.76%866K | 21.56%1.42M | 18.00%4.47M | 83.42%2.03M | -77.98%248K | 21.95%1.03M | 63.71%1.16M | 50.88%3.78M | 66.52%1.1M |
Operating profit | -87.55%565K | -113.12%-203K | -177.91%-3.41M | -93.64%213K | -34.74%-4.65M | 27.36%4.54M | -57.58%1.55M | -197.82%-1.23M | -28.84%3.35M | -749.26%-3.45M |
Net non-operating interest income expense | 143.68%701K | -601.24%-1.61M | -334.21%-3.85M | -4.13%-10.54M | -697.95%-10.9M | 74.27%-1.61M | -18.07%322K | 156.42%1.64M | 53.85%-10.12M | 88.52%-1.37M |
Non-operating interest income | 197.78%4.55M | -30.75%2.38M | -86.71%631K | 401.24%2.02M | -240.83%-7.68M | 81.16%1.53M | -5.21%3.44M | 486.77%4.75M | 51.13%402K | -8.32%-2.25M |
Non-operating interest expense | 18.74%3.71M | 28.16%3.84M | 32.75%3.77M | 22.93%12.06M | 586.50%3.1M | -3.37%3.12M | -6.06%2.99M | -3.40%2.84M | -0.76%9.81M | 804.00%452K |
Total other finance cost | 1,108.33%145K | 28.00%160K | 167.04%713K | -30.40%499K | 108.81%118K | -99.69%12K | 150.00%125K | -65.94%267K | -94.18%717K | -113.71%-1.34M |
Other net income (expense) | 82.11%6.28M | 1,526.63%2.84M | 44.15%1.82M | 43.95%11.3M | 8.09%6.79M | 87.96%3.45M | 56.83%-199K | 541.62%1.26M | 237.49%7.85M | 212.32%6.28M |
Gain on sale of security | -123.02%-90K | 512.10%2.32M | 523.26%536K | 5.07%6.98M | 25.52%7.07M | -42.25%391K | -251.08%-562K | 352.94%86K | 214.04%6.65M | 203.80%5.63M |
Earnings from equity interest | 14.00%3.49M | 44.08%523K | 9.17%1.29M | 258.21%4.32M | -142.92%-279K | 164.08%3.06M | 143.58%363K | 409.96%1.18M | 930.77%1.21M | 489.22%650K |
Other non- operating income (expenses) | --2.89M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Income before tax | 18.24%7.55M | -38.80%1.02M | -423.57%-5.44M | -9.71%976K | -696.93%-8.76M | 861.69%6.38M | -53.34%1.67M | 153.73%1.68M | 104.71%1.08M | 108.20%1.47M |
Income tax | 58.20%916K | -217.65%-160K | 38.76%-828K | -186.92%-1.44M | -168.12%-799K | -32.91%579K | -83.17%136K | -584.59%-1.35M | 165.14%1.65M | 90.96%-298K |
Net income | 12.83%6.63M | 22.03%1.57M | -250.27%-4.92M | 346.43%625K | -496.41%-9.82M | 445.50%5.88M | -53.48%1.29M | 196.12%3.27M | 100.71%140K | 117.89%2.48M |
Net income continuous Operations | 14.25%6.63M | -22.95%1.18M | -251.98%-4.61M | 522.42%2.41M | -550.88%-7.96M | 441.21%5.8M | -44.64%1.53M | 189.02%3.03M | 97.20%-571K | 112.09%1.77M |
Net income discontinuous operations | --0 | 259.59%391K | -228.93%-312K | -351.34%-1.79M | ---1.86M | --73K | ---245K | --242K | -6.32%711K | ---- |
Minority interest income | -18.17%527K | -471.70%-606K | -61.96%-1.31M | -420.72%-1.59M | -39.03%-1.33M | -25.38%644K | -110.01%-106K | -70.97%-807K | 110.92%497K | 82.63%-953K |
Net income attributable to the parent company | 16.64%6.1M | 56.20%2.18M | -188.53%-3.61M | 721.57%2.22M | -347.59%-8.49M | 304.10%5.23M | -18.52%1.4M | 239.09%4.08M | 97.63%-357K | 141.06%3.43M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 16.64%6.1M | 56.20%2.18M | -188.53%-3.61M | 721.57%2.22M | -347.59%-8.49M | 304.10%5.23M | -18.52%1.4M | 239.09%4.08M | 97.63%-357K | 141.06%3.43M |
Basic earnings per share | 14.63%0.47 | -63.64%0.04 | -203.70%-0.28 | 666.67%0.17 | -344.44%-0.66 | 305.00%0.41 | -15.38%0.11 | 217.39%0.27 | 97.46%-0.03 | 141.54%0.27 |
Diluted earnings per share | 14.63%0.47 | -63.64%0.04 | -203.70%-0.28 | 666.67%0.17 | -344.44%-0.66 | 305.00%0.41 | -15.38%0.11 | 217.39%0.27 | 97.46%-0.03 | 141.54%0.27 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |